Lindsey Kraft
Medical · Louisville, KYNPI 1538814835
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations.
Across 139 payments — averaging $28.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$555
- Novo Nordisk$410
- Phathom Pharmaceuticals, Inc.$404
- Pfizer$368
- Amgen$326
- AstraZeneca$205
- plus $2K from 26 others
What the payments were for
- Food & beverage$3,933100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $555 |
| Novo Nordisk | 13 | $410 |
| Phathom Pharmaceuticals, Inc. | 5 | $404 |
| Pfizer | 17 | $368 |
| Amgen | 19 | $326 |
| AstraZeneca | 7 | $205 |
| Astellas Pharma US Inc | 5 | $180 |
| Idorsia Pharmaceuticals US Inc | 4 | $175 |
| Bayer | 4 | $154 |
| GSK | 7 | $144 |
| Lilly USA, LLC | 7 | $127 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $118 |
| Arcutis Biotherapeutics, Inc. | 1 | $113 |
| Exact Sciences | 3 | $73 |
| Boehringer Ingelheim | 4 | $59 |
| Merz North America, Inc. | 2 | $43 |
| Almatica Pharma LLC | 2 | $38 |
| Novartis | 2 | $33 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
| Ardelyx, Inc. | 1 | $29 |
| Esperion Therapeutics, Inc. | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Tolmar, Inc. | 1 | $21 |
| Corcept Therapeutics | 1 | $21 |
| Dexcom, Inc. | 1 | $21 |
| Mylan Specialty L.p. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Verona Pharma, Inc. | 1 | $16 |
| Abbott | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,933 in reported general payments places this provider in the 75th percentile of 222 medical providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 45 | $57,238 |
| JardianceEmpagliflozin | 41 | $46,025 |
| Spiriva RespimatTiotropium Bromide | 43 | $42,217 |
| TrulicityDulaglutide | 22 | $36,704 |
| FarxigaDapagliflozin Propanediol | 19 | $27,093 |
| MounjaroTirzepatide | 19 | $21,216 |
| LinzessLinaclotide | 29 | $18,775 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 20 | $13,847 |
| XareltoRivaroxaban | 13 | $13,810 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $13,381 |
| MyrbetriqMirabegron | 23 | $12,647 |
| SymbicortBudesonide/Formoterol Fumarate | 23 | $9,663 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 11 | $6,375 |
| PaxlovidNirmatrelvir/Ritonavir | 16 | $4,208 |
| Atorvastatin Calcium | 344 | $2,890 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat | $59 | $102,089104 claims |
| PfizerEliquis, Paxlovid | $368 | $61,44661 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $127 | $57,92041 claims |
| AstraZenecaFarxiga, Symbicort | $205 | $36,75642 claims |
| AbbVieLinzess, Synthroid | $555 | $20,37055 claims |
| GSKTrelegy Ellipta | $144 | $13,38121 claims |
| Astellas Pharma US IncMyrbetriq | $180 | $12,64723 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $30 | $6,37511 claims |
| Almatica Pharma LLCSertraline Hcl | $38 | $1,289121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 222 medical providers in Kentucky.
Other medical in Louisville
- Alexandra HuettLouisville$13K
- Mitzi CarterLouisville$5K
- Kristen YoungLouisville$5K
- Kacie LawLouisville$4K
- Elizabeth ArnoldLouisville$3K
- Kristen HordLouisville$3K
- William BriggsLouisville$3K
- Mikal BaileyPaducah$84K
- Kyle HeraldBowling Green$65K
- Chasity HesterLexington$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.